Background/Aims: Borna disease virus 1 (BoDV-1) infection induces cognitive impairment in rodents. Emerging evidence has demonstrated that Chromatin remodeling through histone acetylation can regulate cognitive function. In the present study, we investigated the epigenetic regulation of chromatin that underlies BoDV-1-induced cognitive changes in the hippocampus. Methods: Immunofluorescence assay was applied to detect BoDV-1 infection in hippocampal neurons and Sprague-Dawley rats models. The histone acetylation levels both in vivo and vitro were assessed by western blots. The acetylation-regulated genes were identified by ChIP-seq and verified by RT-qPCR. Cognitive functions were evaluated with Morris Water Maze test. In addition, Golgi staining, and electrophysiology were used to study changes in synaptic structure and function. Results: BoDV-1 infection of hippocampal neurons significantly decreased H3K9 histone acetylation level and inhibited transcription of several synaptic genes, including postsynaptic density 95 (PSD95) and brain-derived neurotrophic factor (BDNF). Furthermore, BoDV-1 infection of Sprague Dawley rats disrupted synaptic plasticity and caused spatial memory impairment. These rats also exhibited dysregulated hippocampal H3K9 acetylation and decreased PSD95 and BDNF protein expression. Treatment with the HDAC inhibitor, suberanilohydroxamic acid (SAHA), attenuated the negative effects of BoDV-1. Conclusion: Our results demonstrate that regulation of H3K9 histone acetylation may play an important role in BoDV-1-induced memory impairment, whereas SAHA may confer protection against BoDV-1-induced cognitive impairments. This study finds important
Introduction
Bornaviruses (Order Mononegavirales Family Bornaviridae) are phylogenetically diverse, nonsegmented, negative single-stranded RNA viruses [1] [2] [3] . Borna disease virus 1 (BoDV-1), as part of the species Mammalian 1 bornavirus, is a highly neurotropic prototype of Bornaviruses and infects a wide variety of mammal species [4, 5] . BoDV-1 was recently identified as the cause of human death after organ transplantation -the first hard evidence that BoDV-1 can actually infect humans and cause disease [6] . BoDV-1-infection may induce a large spectrum of neurological disorders ranging from immune-mediated acute encephalitis to non-inflammatory behavioral alterations [7, 8] . Previous studies demonstrated that BoDV-1 establishes a persistent infection in the hippocampus and limbic lobe of rodents in the neonatal period, which induced cognitive deficits and mental disorders [4, 9] . Notwithstanding abundant discussion of BoDV-1-driven pathophysiology, the precise mechanism underlying how BoDV-1 disrupts memory is poorly understood.
Chromatin remodeling, especially via histone acetylation, plays a key role in hippocampusdependent cognitive function [10] [11] [12] . Memory formation and synaptic plasticity have been shown to be associated with changes in histone acetylation [13] . Aberrant activity of histone acetyl transferases (HATs) or histone deacetylases (HDACs) can alter the levels of acetylated histones and cause abnormal gene expression [14, 15] . Suberanilohydroxamic acid (SAHA) is an HDAC inhibitor that targets Class I and Class IIb HDACs, causing increased acetylation [16] . Treatment with SAHA can enhance memory formation in rats and mice [17] , and improves memory deficits in animal models of neurodegenerative disorders [18, 19] . Infection with a laboratory BoDV-1 strain affects site-specific histone acetylation in cortical [20] and hippocampal neurons [21] . Moreover, our previous study showed that infection with a human BoDV-1 strain epigenetically impacts the human oligodendroglial (OL) cell proteome through histone acetylation [22] . However, the epigenetic regulation of chromatin that underlies BoDV-1-induced cognitive changes in the hippocampus remains unknown.
In this study we tested the hypothesis that BoDV-1 infection disturbs synaptic plasticity and induces cognitive dysfunction via histone acetylation. Here, we show that infection with a human BoDV-1 strain caused a dramatic decline in the level of H3K9 acetylation, and consequently reduced postsynaptic density 95 (PSD95) and brain-derived neurotrophic factor (BDNF) expression and impaired synaptic plasticity in hippocampal neurons. These changes contributed to BoDV-1-induced cognitive deficits, which were attenuated by the HDAC inhibitor, SAHA.
Materials and Methods

Primary neuronal cultures and viral infection
All animal experiments were approved by the Research Ethics Committee of ChongQing Medical University. Primary hippocampal neurons were prepared from Sprague Dawley rat embryos at gestational day 17 by the 0.125% trypsin (Thermo Fisher Scientific, Waltham, USA) dissociation method, as described previously [23] . At the end of this procedure, neurons were directly plated in six-well culture plates. Before seeding, supports were coated with 500 µg/ml poly-L-lysine (Sigma, St. Louis, USA). Neurons were maintained in Neurobasal medium supplemented with 100 µg/ml penicillin-streptomycin (Sigma), 0.5 mM glutamine, and 2% B-27 supplement (Thermo Fisher Scientific). Half of each culture was infected with human BoDV-1 strain Hu-H1 [24] (kindly provided by Professor Hanns Ludwig, Free University of Berlin, Germany) 5 h after plating. Cultured primary neurons were supplemented with 1 μM SAHA [25] (Sigma) for 48 h or 200 μM favipiravir (T-705) [26] (Selleckchem, Houston, USA) for 7 days for follow-up experiments. 
Animal model and treatments
All behavioral experiments were performed under light conditions between 9:00 h and 16:30 h. All efforts were made to minimize the number of animals used and their suffering. Within 12 h after birth, 30 µl (10 4 FFU/ml) of BoDV-1 (Hu-H1) or PBS was inoculated into the right cerebral hemisphere of Sprague Dawley rat pups. Seven days later, half of the BoDV-1-infected rats were intraperitoneally injected with SAHA (25 mg/kg) for a week. After weaning, control (n=14), SAHA (n=14), and mockinfected (n=14) rats were separated and housed individually. The ratio of males and females was identical among the three groups. Behavioral testing was performed from postnatal day 42 (P42) to P49 and then rats were euthanized at P50 for dissection and subsequent analysis.
Behavioral testing
The Morris water maze (MWM) test was conducted in a circular tank (diameter 1.8 m) filled with opaque water. A platform (11 × 11 cm) was submerged below the water surface in the center of the target quadrant. The whole test consists of a visible platform test (day 1), a hidden platform test (days 2-5) and a probe test 24 hours after the last hidden platform test (day 6). The swimming path of each rat was recorded using a video camera and analyzed using Smart software (v2.5.21). For each training session, the rats were placed into the maze at four random points in the tank. The rats were allowed to search for the platform for 90 s. If they did not find it within this period, they were gently guided towards it and then allowed to remain on it for 15 s. The latency to find the platform for each trial was recorded. During the memory test (probe test), the platform was removed from the tank and the rats were allowed to swim in the maze for 60s.
Golgi staining and analysis
For Golgi staining, we used the FD Rapid Golgi Stain Kit (FD NeuroTechnologies, Ellicott City, MD, USA). Dissected rat brains were immersed in Solutions A and B for 2 weeks at room temperature and then transferred into Solution C for 72h. Brains were sectioned at 100 μm thickness using a VT1000S Vibratome (Leica). These sections were then placed in a mixture of 1 part Solution D, 1 part Solution E, and 2 parts double-distilled water for 10 min, after which the sections were dehydrated and cleared in xylene. Images of dendrites were then acquired using an optical microscope (Nikon). Dendrite branches were reconstructed using Image J software and subjected to Sholl analysis. Spine density was also measured using Image J. All morphological analyses were performed by individuals blinded to the genotypes and experimental conditions.
Electrophysiology
Rats were deeply anesthetized with urethane (1.5 g/kg, i.p.) and transcardially perfused with N-methyl-D-glucamine (NMDG) artificial cerebral spinal fluid (ACSF) prior to decapitation as described previously [28] . The hippocampus was rapidly dissected and acute coronal hippocampal slices 400 μm thick were cut using a vibratome (VT1000 S, Leica Microsystems) in ice-cold cutting solution (NMDG ACSF) bubbled with 5% CO 2 and 95% O 2 . The slices were then incubated in oxygenated ACSF for 2 h at 30°C. Next, the slices were transferred into a recording chamber filled with normal ACSF. Field excitatory postsynaptic potentials (fEPSPs) evoked by stimulation of the Schaffer collateral/commissural pathway were recorded in the hippocampus with pipettes filled with ACSF (1−2 MΩ). Test fEPSPs were evoked at a frequency of 0.033 Hz and at a stimulus intensity that was adjusted to approximately 50% of the intensity that elicited the maximal response. After a stable 30 min baseline recording of fEPSPs, long-term potentiation (LTP) was induced 
Statistical analysis
All data were analyzed using SPSS version 21.0 for Windows (SPSS Inc., USA). Data are expressed as the mean ± SEM. Comparisons among experimental groups were performed using the unpaired t-test and behavioral data were analyzed using one-way ANOVA, followed by Bonferroni's test and Dunnett's T3 test when necessary. In all comparisons, P-values less than 0.05 were considered to indicate statistical significance.
Results
BoDV-1 infection decreases histone acetylation of H3K9
To assess the impact of BoDV-1 infection on histone acetylation, primary neuronal cultures were infected with BoDV-1 and then cultured for 9 days to allow all neurons to be infected with BoDV-1 (Fig. 1A) . Acetylation of H2, H3, and H4 was assessed by western blots using antibodies targeting lysine residues that are known to be acetylated (Fig. 1B) . BoDV-1 infection led to a significant reduction of H3K9 acetylation (58.19% of control, P<0.01). There was no difference in the acetylation of H2BK5, H2BK20, H3K14, and H4K16 between the BoDV-1-infected neurons and controls (Fig. 1C) .
BoDV-1 infection inhibited the expression of H3K9 acetylation-mediated synaptic plasticityrelated genes
The hippocampus is an important target of BoDV-1 infection [29, 30] . Neuronal plasticity plays an important role in cognition. To investigate whether deregulated H3K9 acetylation affects memory formation and synaptic plasticity, we applied ChIP-seq technology to analyze H3K9 acetylation within gene promoter regions that were defined as 1 Kb upstream and 1 Kb downstream of the transcription start site (TSS). The resulting reads were mapped to a reference rat genome. Compared with the control group, 808 genes showed reduction of H3K9 acetylation after BoDV-1 infection.
The genes with remarkable loss of H3K9ac are shown in Table 2 (log2FC<-1, P<0.05). Of these, we found a number of memory formation or synaptic plasticityassociated genes, including PSD95, BDNF, PUM2, VAMP2, SYN1 and DRD1. Chip-Seq analysis confirmed BoDV-1-mediated loss of H3K9 acetylation in the promoters of these genes ( Fig. 2A) . Acetylation of H3K9 indicates an open chromatin state, and the enrichment of H3K9ac near a TSS is closely related to the transcriptional activity of the gene [31] . In BoDV-1-infected neurons, RT-qPCR and western (Fig. 2B-D) . Treatment with the HDAC inhibitor, SAHA, nearly reversed the expression levels of PSD95 and BDNF back to normal. Although the expression levels of other genes were upregulated after the use of SAHA, they were significantly lower than their normal levels, indicating that their expression was affected by histone acetylation to some extent and that other mechanisms were involved in their regulation. These findings demonstrated that BoDV-1-mediated hypoacetylation of H3K9 may be the main mechanism by which BoDV-1 suppressed the transcription of PSD95 and BDNF.
SAHA does not inhibit the proliferation of BoDV-1 and rescues the BoDV-1-induced reduction of H3K9 acetylation
To explore whether SAHA could affect the replication of BoDV-1, we used T-705, a virus-inhibiting drug, as a positive control and observed the effect of SAHA on BoDV-1 by immunofluorescence and RT-qPCR experiments (Fig. 3A-B) . The results showed that the number of virus copies in neurons treated with T-705 was significantly reduced (55.45% of BoDV-1 group, P<0.01), whereas the virus numbers in the control and SAHA-treated neurons were normal. This shows that SAHA does not interfere with the replication of BoDV-1 and that T-705 can significantly inhibit viral replication. In addition, we also observed the effects of SAHA and T-705 on H3K9 acetylation levels in BoDV-1-infected neurons (Fig. 3C) . Western blots showed that SAHA significantly increased H3K9 acetylation levels (181.76% of BoDV-1 group, P<0.01) compared to the T-705-treated group (154.88% of BoDV-1 group, P<0.01). These results suggest that SAHA counteracts the damaging effects of BoDV-1 on synaptic plasticity by altering the level of H3K9 acetylation, rather than by inhibiting viral replication.
BoDV-1 infection impairs spatial learning in rats
To determine the effects of BoDV-1 and SAHA on spatial learning and memory, rats were subjected to a Morris water maze test (Fig. 4A-B) . In the visible platform test, the three groups had similar escape latency (CON: 70.57 ± 4.94, BoDV-1: 73.14 ± 4.81 and SAHA: 69.29 ± 4.14s, P>0.05) (Fig. 4C) , indicating that there was no motor or vision dysfunction in BoDV-1 or SAHA rats.
In the hidden platform test from day 2 to day 5, the escape latency was significantly longer for the BoDV-1 rats compared with the control group (71. 45 (Fig. 4D) . Traces of the movement of rats during the hidden platform test are presented in Fig. 4E . In the probe trial on the last day of testing, BoDV-1 infection resulted in fewer crosses of the target quadrant (4.14 ± 0.38 vs. 6.50 ± 0.62s, P<0.05). However, 
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SAHA treatment improved the performance (6.79 ± 0.65 vs. 4.14 ± 0.38s, P<0.05) (Fig. 4F) . These results demonstrated that BoDV-1 infection significantly impaired cognitive function but SAHA rescued this impaired cognitive ability.
BoDV-1 infection decreases histone acetylation of H3K9 and affects synaptic protein expression in rats
In order to confirm the infection of BoDV-1 in the rat hippocampus, immunofluorescence assay was used for detection (Fig. 5A) . Then, to confirm the effect of BoDV-1 infection on acetylation in vivo, we extracted proteins of rat hippocampus for Western blot analysis. BoDV-1 infection led to a significant decrease of H3K9ac (44.61% of control, P<0.01) (Fig. 5B-C) , consistent with our previous findings in vitro. In addition, SAHA treatment induced an increase of acetylation on H3K9. We next examined the expression of key proteins related to synaptic plasticity.
BoDV-1 infection significantly decreased PSD95 (78.49% of control, P<0.01) and BDNF (67.23% of control, P<0.01) expression in rats. SAHA treatment effectively restored the expression in the BoDV-1-infected rats (Fig.  5D-E) . These results suggest that BoDV-1-induced H3K9 acetylation defect led to synaptic plasticity damage in vivo.
BoDV-1 infection caused abnormalities of synaptic plasticity in rats
To examine the effect of BoDV-1 on synaptic plasticity, the number of dendritic branches and neuronal spine density were examined by using Golgi staining. As shown in Fig. 6 , the mean number of dendritic branches and neuronal dendritic spine density were sharply decreased in the hippocampus of the BoDV-1 group rats compared with those in normal control rats (P<0.05, P<0.01). SAHA treatment significantly increased the number of dendritic branches and the neuronal spine density compared with those in the BoDV-1 group (P<0.05, P<0.01). These findings suggest that BoDV-1 infection caused the structural damage of synaptic plasticity and the effect can be reversed by HDAC inhibition. 
Discussion
Neonatal BoDV-1 infection results in hippocampal alterations and memory dysfunction. Modification of histone acetylation has been implicated in various cognitive processes and multiple neurological disorders [33] . Histone acetylation at lysine residues by HATs causes the remodeling of chromatin structure to an "open" state that promotes gene expression; in contrast, histone deacetylation by HDACs is often associated with transcriptional repression [34, 35] . Although there have been extensive studies on BoDV-1-driven pathophysiology, the effect of BoDV-1 infection on chromosome plasticity and histone modification remains elusive.
In this study, we found that BoDV-1 infection significantly reduced the level of H3K9 acetylation in primary cultures of hippocampal neurons and in BoDV-1-infected rats. A previous study revealed that environmental enrichment significantly increased the levels of acetyl-H3K9 in the hippocampus and cortex of CK-p25 rats, and caused enhanced learning and memory [36] . In addition, in a model of iron-induced memory impairment, levels of H3K9 acetylation were significantly reduced in the hippocampus of rats with neonatal iron overload, but there were no changes in the acetylation levels of H3K14ac, H4K5ac, and H4K12ac [37] . A recent study has also shown that suppressed gene expression and impaired memory are related to the downregulation of histone acetylation of H3K9 and H3K14 [38] . H3K9 is likely to be a target of HDAC1 or 3, which play crucial roles as negative regulators of long-term memory [39] . Our study shows that BoDV-1 infection causes abnormal H3K9 acetylation and memory impairment.
Using ChIP-seq analysis, we found a causative link between H3K9 acetylation deficits and the downregulation of BDNF and PSD95 in BoDV-1-infected neurons. The mRNA and protein levels of BDNF and PSD95 were down-regulated in BoDV-1-infected SD rats. Inhibition of HADC by SAHA treatment rescued the BoDV-1-induced abnormalities in H3K9 acetylation and gene expression. SAHA didn't inhibit the replication of the virus. This also indicates that BoDV-1 causes synaptic plasticity-related damage through abnormal acetylation.
It is well known that BDNF and PSD95 are closely related to memory formation and synaptic plasticity. BDNF is a member of a family of neurotrophic factors critically involved in regulating the survival and differentiation of neurons [40] , and in increasing dendritic spine density in an ERK-dependent manner [41] . Moreover, hippocampal-specific deletion of the BDNF gene impairs novel object recognition and spatial learning in the water maze [42] . PSD95 is expressed in the hippocampus and prefrontal cortex and plays a key role in controlling both synaptic strength [43, 44] and synaptic plasticity at excitatory synapses [45] . Decreased levels of PSD95 can lead to the disruption of synaptic structures [46] and neuronal apoptosis [47] . BDNF and PSD95 are regulated by H3K9ac. In rat hippocampal cultures, the HDAC-inhibitor, TSA, increases H3K9 histone acetylation, promotes BDNF exon I transcription, and rescues age-dependent decline in hippocampal LTP and BDNF gene expression [48] .
Finally, Morris water maze testing showed that BoDV-1 caused spatial memory impairment. We discovered that the mean dendritic spine density and the number of dendritic branches were sharply decreased in the hippocampus of BoDV-1 group rats. In addition, electrophysiological tests showed that BoDV-1 infection reduced the induction of LTP in the hippocampus and impaired synaptic plasticity. However, treatment with SAHA attenuated these negative effects of BoDV-1. These findings further demonstrate that the regulation of H3K9 histone acetylation may play important roles in BoDV-1-induced spatial memory impairment, whereas an HDAC inhibitor may confer protection against BoDV-1-induced impairments in spatial memory and hippocampal functions (Fig. 8 ). An abnormal Cellular Physiology and Biochemistry
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BoDV-1-induced H3K9 acetylation level may impair synaptic plasticity through PSD95 and BDNF, thereby damaging memory formation.
In conclusion, abnormal BoDV-1-induced H3K9 acetylation levels may impair synaptic plasticity through PSD95 and BDNF, thereby damaging memory formation. Our study reveals a novel mechanism by which BoDV-1 infection causes cognitive impairments from the perspective of histone modification. Fig. 8 . Schematic diagram illustrates how BoDV-1 induces memory decline in SD rats. We propose that BoDV-1 decreases acetylated histone H3K9 and thus the enrichment in the promoter region of PSD95 and BDNF. This leads to the lower transcription and translation of PSD95 and BDNF in the hippocampus that impair synaptic plasticity, eventually cause memory damage.
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